2022
DOI: 10.1101/2022.07.27.501720
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

TROP2 represents a negative prognostic factor in colorectal adenocarcinoma and its expression is associated with features of epithelial-mesenchymal transition and invasiveness

Abstract: Trophoblastic cell surface antigen 2 (TROP2) is a membrane glycoprotein overexpressed in many solid tumors with poor prognosis, including intestinal neoplasms. In our study, we show that TROP2 is expressed in preneoplastic lesions and its expression is maintained in most colorectal cancer (CRC). High TROP2 positivity correlated with lymph node metastases and poor tumor differentiation and was a negative prognostic factor. To investigate the role of TROP2 in intestinal tumors, we analyzed two mouse models with … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 130 publications
0
1
0
Order By: Relevance
“…Trop2 has shown identical characteristics to EpCAM in virtually all features examined so far, including structure and biochemical interactions (Fagotto, 2020a; Fagotto and Aslemarz, 2020). Trop2 has been also linked to cancer, but, again, its actual role remains to be established (Fagotto and Aslemarz, 2020; Lenárt et al, 2020; Švec et al, 2022).…”
Section: Introductionmentioning
confidence: 99%
“…Trop2 has shown identical characteristics to EpCAM in virtually all features examined so far, including structure and biochemical interactions (Fagotto, 2020a; Fagotto and Aslemarz, 2020). Trop2 has been also linked to cancer, but, again, its actual role remains to be established (Fagotto and Aslemarz, 2020; Lenárt et al, 2020; Švec et al, 2022).…”
Section: Introductionmentioning
confidence: 99%